Found 12 matching trials
Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis PHASE1 Tolerogenic dendritic cell (tDC)-based clinical trials for the treatment of...
Show More Location
Institute of Fundamental and Clinical Immunology
Learn More & Join Trial
Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients PHASE1 The ATDC-PICI study is a Phase Ib, single-arm, prospective, non-randomized,...
Show More Location
Hospital Germans Trias i Pujol
Learn More & Join Trial
Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis PHASE1 Rationale: In rheumatoid arthritis, immune cells cause joint inflammation a...
Show More Location
Radboud University Medical Centre
Learn More & Join Trial
A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis PHASE2 The investigators propose to design and conduct a phase IIa clinical trial ...
Show More Location
Universitair Ziekenhuis Antwerpen (UZA)
Learn More & Join Trial
Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis PHASE2 The aim of this project is to assess properly the clinical efficacy of TolD...
Show More Status
Active Not Recruiting
Location
Hospital Moisés Broggi
Learn More & Join Trial
Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) PHASE1 This is a study which will look at safety, feasibility and acceptability of...
Show More Location
Newcastle University
Learn More & Join Trial
The ONE Study ATDC Trial PHASE1 To collect evidence of the safety of administering autologous tolerogenic d...
Show More Location
Nantes University hospital
Learn More & Join Trial
First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers PHASE1 Tha aim of this clinical trial is to evaluate safety and tolerability of au...
Show More Learn More & Join Trial
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes PHASE1 This phase I trial investigates the side effects of PIpepTolDC vaccine in t...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) PHASE1 The purpose of this study is to determine the safety and tolerability of th...
Show More Location
Hospital Universitari Germans Trias i Pujol
Learn More & Join Trial